Literature DB >> 21259069

Cardio-renal syndromes: from foggy bottoms to sunny hills.

Claudio Ronco1.   

Abstract

"Cardio-renal syndromes" (CRS) are disorders of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. The current definition has been expanded into five subtypes whose etymology reflects the primary and secondary pathology, the time-frame and simultaneous cardiac and renal co-dysfunction secondary to systemic disease: CRS type I: acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction. CRS type II: chronic abnormalities in heart function (CHF-CHD) leading to kidney injury or dysfunction. CRS type III: acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction. CRS type IV: chronic kidney disease (CKD) leading to heart injury, disease and/or dysfunction. CRS type V: systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney. These different subtypes may have a different pathophysiological mechanism and they may represent separate entities in terms of prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21259069     DOI: 10.1007/s10741-011-9226-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  83 in total

1.  Cardiogenic shock secondary to combination of diltiazem and sotalol.

Authors:  H Yorgun; A Deniz; K Aytemir
Journal:  Intern Med J       Date:  2008-03       Impact factor: 2.048

2.  Aggressive diuresis for severe heart failure in the elderly.

Authors:  P A Howard; M I Dunn
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

3.  Cardiovascular disease risk factors in chronic renal insufficiency.

Authors:  M J Sarnak; B E Coronado; T Greene; S R Wang; J W Kusek; G J Beck; A S Levey
Journal:  Clin Nephrol       Date:  2002-05       Impact factor: 0.975

4.  Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.

Authors:  Powell Jose; Hicham Skali; Nagesh Anavekar; Charles Tomson; Harlan M Krumholz; Jean L Rouleau; Lemuel Moye; Marc A Pfeffer; Scott D Solomon
Journal:  J Am Soc Nephrol       Date:  2006-08-23       Impact factor: 10.121

Review 5.  A review of the effects of correction of acidosis on nutrition in dialysis patients.

Authors:  J P Brady; J A Hasbargen
Journal:  Semin Dial       Date:  2000 Jul-Aug       Impact factor: 3.455

Review 6.  Acute decompensated heart failure and the cardiorenal syndrome.

Authors:  Kelly V Liang; Amy W Williams; Eddie L Greene; Margaret M Redfield
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 7.  Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes.

Authors:  Alexandre Mebazaa; Mihai Gheorghiade; Ileana L Piña; Veli-Pekka Harjola; Steven M Hollenberg; Ferenc Follath; Andrew Rhodes; Patrick Plaisance; Edmond Roland; Markku Nieminen; Michel Komajda; Alexander Parkhomenko; Josep Masip; Faiez Zannad; Gerasimos Filippatos
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 8.  Beyond serum creatinine: defining the patient with renal insufficiency and why?

Authors:  Peter A McCullough
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

9.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

10.  Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong.

Authors:  Claudio Ronco; Andrew A House; Mikko Haapio
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

View more
  3 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

Authors:  Christian A Schmittinger; Christian Torgersen; Günter Luckner; Daniel C H Schröder; Ingo Lorenz; Martin W Dünser
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

3.  New-onset supraventricular arrhythmia during septic shock: prevalence, risk factors and prognosis.

Authors:  Aurélien Seemann; Florence Boissier; Keyvan Razazi; Guillaume Carteaux; Nicolas de Prost; Christian Brun-Buisson; Armand Mekontso Dessap
Journal:  Ann Intensive Care       Date:  2015-09-22       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.